Picture of Iqvia Holdings logo

IQV Iqvia Holdings Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Annual income statement for Iqvia Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue11,08811,35913,87414,41014,984
Cost of Revenue
Gross Profit3,7883,8594,6415,0285,239
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses10,33510,64112,50712,61113,013
Operating Profit7537181,3671,7991,971
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes3523731,1281,3631,459
Provision for Income Taxes
Net Income After Taxes2363019651,1031,358
Minority Interest
Equity in Affiliates
Net Income Before Extraordinary Items
Extraordinary Items
Net Income1912799661,0911,358
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income1912799661,0911,358
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS1.291.75.165.847.74